EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lung‐Targeted Lipid Nanoparticle‐Delivered siUSP33 Attenuates SARS‐CoV‐2 Replication and Virulence by Promoting Envelope Degradation

Yuzheng Zhou iD, Yujie Liao, Lujie Fan, Xiafei Wei, Qiang Huang, Chuwei Yang, Wei Feng, Yezi Wu, Xiang Gao, Xiaotong Shen, Jian Zhou, Zanxian Xia iD und 1 weitere

Advanced Science · 2024-11 · 11 (42)

DOI: 10.1002/advs.202406211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 20.09.2024. Verfasst von Yuzheng Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital,…. Hauptthemen laut MEDLINE: SARS-CoV-2, Nanoparticles, Virus Replication, COVID-19. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Major Project of Guangzhou National Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a structural protein of SARS‐CoV‐2, the envelope (E) protein not only plays a key role in the formation of viral particles, but also forms ion channels and has pathogenic functions, including triggering cell death and inflammatory responses. The stability of E proteins is controlled by the host ubiquitin‐proteasome system. By screening human deubiquitinases, it is found that ubiquitin‐specific protease 33 (USP33) can enhance the stability of E proteins depending on its deubiquitinase activity, thereby promoting viral replication. In the absence of USP33, E proteins are rapidly degraded, leading to a reduced viral load and inflammation. Using lipid nanoparticle (LNP) encapsulation of siUSP33 by adjusting the lipid components (ionizable cationic lipids), siUSP33 is successfully delivered to mouse lung tissues, rapidly reducing USP33 expression in the lungs and maintaining knockdown for at least 14 days, effectively suppressing viral replication and virulence. This method of delivery allows efficient targeting of the lungs and a response to acute infections without long‐term USP33 deficiency. This research, based on the deubiquitination mechanism of USP33 on the E protein, demonstrates that LNP‐mediated siRNA delivery targeting USP33 plays a role in antiviral and anti‐inflammatory responses, offering a novel strategy for the prevention and treatment of SARS‐CoV‐2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2NanoparticlesVirus ReplicationCOVID-19LungAnimalsMiceVirulenceHumansViral Envelope ProteinsLiposomesUbiquitin ThiolesteraseDisease Models, AnimalRNA, Small Interfering

Stichwörter der Autor:innen

SARS‐CoV‐2USP33deubiquitinaseenvelope (E)lipid nanoparticles

Substanzen

Lipid NanoparticlesViral Envelope ProteinsLiposomesUbiquitin ThiolesteraseRNA, Small Interfering

Autor:innen und Institutionen

  • Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Sh…
  • Department of Cell Biology, School of Life Sciences, Central South University, Changsha, 410083, China.
  • Guangzhou Laboratory, Guangzhou, 510700, China.
  • Hunan Key Laboratory of Animal Models for Human Diseases, Hunan Key Laboratory of Medical Genetics & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410013, China.
  • Shenzhen Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Shenzhen, 518112, China.

ORCID-Profile: Yuzheng Zhou, Zanxian Xia, Zheng Zhang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Major Project of Guangzhou National Laboratory
  • Chinese Academy of Medical Sciences Clinical and Translational Medicine Research Project
  • National Science Fund for Distinguished Young Scholars
  • Guangdong Science and Technology Plan Project, construction of high-level biosafety laboratories
  • Shenzhen Science and Technology Program
  • Guangdong Basic and Applied Basic Research Foundation

Zitieren

APA

Zhou, Y., Liao, Y., Fan, L., Wei, X., Huang, Q., Yang, C., Feng, W., Wu, Y., Gao, X., Shen, X., Zhou, J., Xia, Z., & Zhang, Z. (2024). Lung‐Targeted Lipid Nanoparticle‐Delivered siUSP33 Attenuates SARS‐CoV‐2 Replication and Virulence by Promoting Envelope Degradation. Advanced Science, 11(42). https://doi.org/10.1002/advs.202406211

Vancouver

Zhou Y, Liao Y, Fan L, Wei X, Huang Q, Yang C, et al. Lung‐Targeted Lipid Nanoparticle‐Delivered siUSP33 Attenuates SARS‐CoV‐2 Replication and Virulence by Promoting Envelope Degradation. Advanced Science. 2024;11(42). doi:10.1002/advs.202406211

BibTeX
@article{Zhou2024,
  author = {Zhou, Yuzheng and Liao, Yujie and Fan, Lujie and Wei, Xiafei and Huang, Qiang and Yang, Chuwei and Feng, Wei and Wu, Yezi and Gao, Xiang and Shen, Xiaotong and Zhou, Jian and Xia, Zanxian and Zhang, Zheng},
  title = {Lung‐Targeted Lipid Nanoparticle‐Delivered siUSP33 Attenuates SARS‐CoV‐2 Replication and Virulence by Promoting Envelope Degradation},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {42},
  doi = {10.1002/advs.202406211}
}
Kostenlos starten →